title: Porous tantalum patellar components in revision total knee arthroplasty minimum 5-year follow-up.
abstract: Revision total knee arthroplasty can be complicated by severe patellar bone loss, precluding the use of standard cemented patellar components. This study evaluated the midterm outcomes of porous tantalum (PT) patellar components. Twenty-three PT components were used in 6 men and 17 women (average age, 62 years). All patellae had less than 10-mm residual thickness. The PT shell was secured to host bone, and a 3-peg polyethylene component was cemented onto the shell. In 2 patients, the PT component was sutured directly to extensor mechanism. Average follow-up was 7.7 years (range, 5-10 years). At follow-up, the Knee Society scores for pain and function averaged 82.7 and 33.3, respectively, whereas the mean Oxford knee score was 32.6. Four patients underwent revision surgery. Survivorship was 19 (83%) of 23 patients. Porous tantalum patellar components can provide fixation where severe bone loss precludes the use of traditional implants. Failures were associated with avascular residual bone and fixation of components to the extensor mechanism.
authors.affiliation: Department of Orthopaedic Surgery, Hospital of the University of Pennsylvania, Philadelphia, USA.
authors.forename: Atul F
authors.initials: AF
authors.lastname: Kamath
authors.forename: Albert O
authors.initials: AO
authors.lastname: Gee
authors.forename: Charles L
authors.initials: CL
authors.lastname: Nelson
authors.forename: Jonathan P
authors.initials: JP
authors.lastname: Garino
authors.forename: Paul A
authors.initials: PA
authors.lastname: Lotke
authors.forename: Gwo-Chin
authors.initials: GC
authors.lastname: Lee
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D019645:Arthroplasty, Replacement, Knee / Q000009:adverse effects; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007720:Knee Prosthesis; D008297:Male; D008875:Middle Aged; D010329:Patella / Q000601:surgery; D016062:Porosity; D011474:Prosthesis Design; D012086:Reoperation; D012189:Retrospective Studies; D013635:Tantalum; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D013635:Tantalum